These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Indication and results of pancreatectomy with combined resection of vessels for adenocarcinoma of the pancreas].
    Author: Ogata Y, Hishinuma S, Takahashi S, Matsui J, Ozawa I.
    Journal: Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):615-21. PubMed ID: 9276868.
    Abstract:
    Of 192 patients who received pancreatectomy for invasive adenocarcinoma of the pancreas, 107 (55. 7%) underwent combined resection of vessels at Keio University Hospital and Tochigi Cancer Center, from July 1974 until March 1996. Vascular resections included the portal and/or mesenteric vein in 103, the common hepatic artery in 14, the superior artery in 2 and the celiac axis in 5 cases. The morbidity and mortality rate are 20.2%, 1.2% in the standard resected group and 23.1%, 5.6% in the vessel resected group, respectively. Comparison of the survival rate of curability A and B patients between two groups shows no significant difference. Six patients who underwent resection of the portal and/or mesenteric vein survived more than 5 years. The longest survivor is living 13 years 6 months after surgery. Among the patients who underwent resection of the artery, two patients survived 44 and 22 months after distal pancreatectomy with resection of the celiac axis and the common hepatic artery preserving whole stomach.
    [Abstract] [Full Text] [Related] [New Search]